Current Gene Therapy
Country
United Arab Emirates
Middle East
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Drug Discovery
Q2
└
Genetics
Q2
└
Genetics (clinical)
Q3
Publisher
SJR 2025
0.706
Q2
SJR Score
H-Index
85
Citations / Doc (2yr)
3.03
Total Docs. (latest)
96
Total Citations (3yr)
371
Publication type
Journals
ISSN
18755631, 15665232
Coverage
2001-2025
Journal Rank
#8,167
Subject Categories
Drug Discovery
Q2
Genetics
Q2
Genetics (clinical)
Q3
Molecular Biology
Q3
Molecular Medicine
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 96 |
| Total Docs. (3 years) | 112 |
| Total Refs. | 9,746 |
| Total Citations (3 years) | 371 |
| Citable Docs. (3 years) | 105 |
| Citations / Doc. (2 years) | 3.03 |
| Ref. / Doc. | 101.52 |
| % Female | 40.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Current Gene Therapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Current Gene Therapy has an SJR of 0.706 and is ranked Q2.
What is the SJR and quartile of Current Gene Therapy?
Current Gene Therapy has an SJR (SCImago Journal Rank) of 0.706 and its best quartile is Q2.
What is the H-index of Current Gene Therapy?
The H-index of Current Gene Therapy is 85, meaning 85 of its articles have each been cited at least 85 times.
Is Current Gene Therapy indexed in Scopus?
Yes. Current Gene Therapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.